SS Innovations International (SSII) Net Income towards Common Stockholders (2016 - 2026)
SS Innovations International (SSII) posted Net Income towards Common Stockholders of -$3.6 million for Q1 2026, down 165.34% sequentially from $5.5 million in Q4 2025, and up 20.18% YoY from -$3.0 million in Q1 2025.
SS Innovations International (SSII) Net Income towards Common Stockholders (2016 - 2026) Analysis & Trends
SS Innovations International has reported Net Income towards Common Stockholders for 11 years, with the latest figure at -$3.6 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 20.18% year-over-year to -$3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 224.31% YoY) and the FY2025 annual result came in at -$8.2 million, down 1052.11% from the prior year.
- Net Income towards Common Stockholders retreated to -$3.6 million in Q1 2026 per SSII's latest filing, from $5.5 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $12.9 million in Q4 2024 and troughed at -$16.9 million in Q4 2023.
- A 5-year average of -$1.8 million and a median of -$1.9 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2023 and 2024: Net Income towards Common Stockholders sank 3620.87% in 2023, then surged 176.42% in 2024.
- Over 5 years, Net Income towards Common Stockholders stood at -$998076.0 in 2022, then tumbled by 1591.37% to -$16.9 million in 2023, then soared by 176.42% to $12.9 million in 2024, then slumped by 57.5% to $5.5 million in 2025, then sank by 165.34% to -$3.6 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$3.6 million, $5.5 million, and -$3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | SS Innovations International | 706.48 Mn | 684.18 Mn | 7.10 Mn | -2.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.66 Mn |
| Mar 31, 2026 | -3.58 Mn |
| Dec 31, 2025 | 5.48 Mn |
| Sep 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -256,691.00 |
| Mar 31, 2025 | -4.49 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Sep 30, 2024 | -6.12 Mn |
| Jun 30, 2024 | -2.93 Mn |
| Mar 31, 2024 | -2.80 Mn |
| Dec 31, 2023 | -16.88 Mn |
| Sep 30, 2023 | -1.22 Mn |
| Jun 30, 2023 | -1.85 Mn |
| Mar 31, 2023 | -2.99 Mn |
| Dec 31, 2022 | -998,076.00 |
| Sep 30, 2022 | -456,494.00 |
| Jun 30, 2022 | -788,423.00 |
| Mar 31, 2022 | -80,421.00 |
| Dec 31, 2021 | -352,956.00 |
| Sep 30, 2021 | -418,209.00 |